The aim of this work was to study whether epigenetic events at conception influence the formation of behavioral features found in adult rats. First generational inheritance of activity level, anxiety like behavior, and learning ability was studied. To separate genetic and non-genetic inheritance, mating of males and females with average motor activity was carried out in the presence anesthetized or conscious males with high or low activity. Our results show that offspring of parents who mated in the presence of males with a high motor activity were significantly more active than offspring of parents that were paired in the presence of males with low activity. Anxiety like behavior and learning ability were not inherited in this way. It is possible that the phenomenon we discovered is important for maintaining a certain level of activity of specific populations of animals. It counteracts natural selection, which should lead to a constant increase in the activity of animals.
The aim of this work was to study whether epigenetic events at conception influence the formation of behavioral features found in adult rats. First generational inheritance of activity level, anxiety, and learning ability was studied. To separate genetic and non-genetic inheritance, mating of males and females with average motor activity was carried out in the presence males with high or low activity. Our results show that offspring of parents who mated in the presence of males with a high motor activity were significantly more active than offspring of parents that were paired in the presence of males with low activity. Anxiety level and learning ability were not inherited in this way. It is possible that the phenomenon we discovered is important for maintaining a certain level of activity of specific populations of animals. It counteracts natural selection, which should lead to a constant increase in the activity of animals.
INTRODUCTION: Use of sodium glutamate solution with food is a widely spread practice. The glutamate-ergic system has been shown to directly participate in the mechanisms of depression, however, up to the moment, no data have been found to evidence that use of sodium glutamate causes depression. AIM: To study the effect of intake of sodium glutamate on the formation of depression-like behavior in male rats. MATERIALS AND METHODS: Formation of depression-like behavior was evaluated in male rats of Wistar line with 230 g250 g weight at the beginning of the experiment in the situation of inescapable swimming according to the method of R. D. Porsolt, and of hanging by the tail according to T. A. Voronina. In the course of the experiment, the rats of the experimental group consumed 1.1% sodium glutamate solution daily for 30 days, the control animals drank water. During the experiment, the rats were kept in individual cages and had free access to water. The animals of the control group (n = 7) had only water in the drinking bowls. The animals of the experimental group (n = 7) were given water in one drinking bowl and 60 mМ (1.1%) sodium glutamate solution (Henan Lotus Flower Gourmet Powder Cо., LTD, China) in the other. RESULTS: Consumption of 1.1% sodium glutamate solution for 30 days led to reduction of the time of active movements and to increase in the number of periods of immobilization in animals in both tests. Besides, in the tests for depression-like behavior of animals, increased rhythmologic index of depression was found in the group of rats receiving sodium glutamate solution. CONCLUSION: Based on the results of study, it was found that chronic voluntary consumption of 60 mM (1.1%) sodium glutamate solution for 30 days provokes the formation of depression-like behavior in rats.
19 October 2020 in I.P. Pavlov Russian Medical Biological Herald
Aim. A comparative study of the influence of nitric oxide synthase (NO-synthase) inhibitors on the parameters of anxiety, motor activity and pain sensitivity of rats. Materials and Methods. The work was conducted on male rats of Wistar line. The anxiety level and locomotor activity of rats were studied in the elevated plus maze (EPM) test. Pain sensitivity of the animals was tested on the hotplate apparatus. In the work, selective inhibitor of inducible isoform of NO-synthase aminoguanidine at a dose of 50 mg/kg, and non-selective inhibitor of this enzyme N-nitro-L-arginine at a dose of 50 mg/kg, were used. Rats of the control group were introduced the equivalent quantity of normal saline. NO-synthase inducible inhibitor aminoguadinine did not produce any influence on the anxiety level, but led to reduction of the horizontal motor activity of rats. Introduction of non-selective NO-synthase inhibitor N-nitro-L-arginine was accompanied by reduction of the anxiety and of the locomotor activity of animals in the EPM test. Both investigated NO-synthase inhibitors induced alteration of pain sensitivity of rats in the form of hypoalgesia. Here, the most pronounced nociceptive effect was observed with introduction of non-selective NO-synthase inhibitor. Conclusion. In the work the evidence of participation of inducible isoform of NO-synthase in realization of the motor activity and pain sensitivity processes in rats is shown. In result of the conducted experiments it was found that introduction of non-selective NO-synthase inhibitor N-nitro-L-arginine was accompanied by evident alterations of anxious behavior, locomotor activity and nociceptive sensitivity of rats. The results obtained confirm the important role of the system of regulation of nitric oxide synthesis in neurochemical mechanisms of behavioral reactions in rats.
24 October 2026 in Meditsinskiy sovet = Medical Council
Introduction . The prevalence of gastroesophageal reflux disease (GERD) (825–830 million people) and obesity (over 1 billion people) is rising globally, and obesity is a proven pathogenetic factor in the development of GERD. Modern obesity treatments include the use of GLP-1 receptor agonists or dual GIP/GLP-1 receptor agonists (tirzepatide). Aim . To evaluate the prospects of using tirzepatide as a pathogenetic therapy for GERD in patients with obesity. Materials and methods. A search of publications in the PubMed/MEDLINE database covering the period 2021–2026 was conducted using the following terms: obesity, gastroesophageal reflux disease, tirzepatide, gastric emptying, gastrointestinal adverse events, protein intake, lean mass, nutrition, hydration. Additionally, a key mechanistic study and clinical guidelines were analyzed. Results . The article presents the clinical-pharmacological characteristics of GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists with a focus on obesity treatment: mechanisms of action, clinical trial data on tirzepatide (evaluating efficacy and safety), and the main gastrointestinal adverse effects, including their dose-dependency and transient nature. A comprehensive overview of these drugs has been compiled for gastroenterologists, highlighting the increase in both prescribed and self-initiated use, typical adverse effects, and potential applications for the pathogenetic treatment of GERD. A novel multidisciplinary algorithm for managing GERD patients undergoing therapy with these agents is also discussed. The risks of microand macronutrient status disturbances during obesity treatment are outlined, and recommendations for nutritional support for patients receiving tirzepatide are provided. Conclusion. Tirzepatide is a highly effective agent for treating obesity with a favorable mediumand long-term safety profile; however, its use may be associated with a range of short-term gastrointestinal side effects that can be managed through active monitoring and a multidisciplinary approach to the care of patients with comorbidities.